Skip to content
rhome
Start my visit
← All treatments

Weekly subcutaneous injection

Tirzepatide

Dual-action GLP-1/GIP support for weight management.

Tirzepatide is the active ingredient behind Mounjaro and Zepbound, acting on both GLP-1 and GIP receptors. rhome's compounded version is prepared to your clinician's prescription by a licensed 503A pharmacy.

From $249 per month1not FDA approved

Start my visitAll treatments
$249per monthStart my visit

Your week

One day a week. The other six are yours.

Tirzepatide is one dose a week, on the day you pick. A month's supply arrives in one box, split into four weekly doses. Your clinician sets the strength and adjusts it as you go.
Mon
Tue
Wed
Thu
Fri
Sat
Sun

Monday is dose day.

Tap a dot to change it. Tirzepatide is once a week; the other six days are yours.

Start my visit

What to expect

Living with Tirzepatide.

  1. 01

    Dual GLP-1/GIP mechanism

  2. 02

    Clinician-managed titration schedule

  3. 03

    Compounded by licensed U.S. pharmacies

  4. 04

    Ongoing monitoring and support

Questions

Straight answers.

Some patients respond better to dual GLP-1/GIP activity. Your clinician will discuss which mechanism fits your history and goals.

Compounded medications are typically self-pay. We provide an itemized receipt you can submit for potential FSA/HSA reimbursement.

Want the longer answer?

Then a box at the door.

Your first month’s supply, four weekly doses in your treatment’s colour, with a card on top with your name on it.

Start my visitStraight answers